External quality assessment for laboratory testing of HLA‐B*15:02 allele in relation to carbamazepine therapy

E-ISSN： 1098-2825|32|2|jcla.22242-jcla.22242

ISSN： 0887-8013

Source： Journal Of Clinical Laboratory Analysis (Electronic), Vol.32, Iss.2, 2018-02, pp. : n/a-n/a

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Increased carbamazepine-related SJS/TEN risk with HLA-B*1502

Reactions Weekly, Vol. 1, Iss. 1183, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Carbamazepine, HLA-B*1502 and risk of Stevens––Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations

By Ferrell P Brent McLeod Howard L

Pharmacogenomics, Vol. 9, Iss. 10, 2008-10 ,pp. : 1543-1546

Future Medicine

Access to resources Recommend Favorite

HLA-B*1502 Allele is Associated with a Cross-reactivity Pattern of Cutaneous Adverse Reactions to Antiepileptic Drugs

By Wang J Zhang J Wu X Yu P Hong Z

The Journal of International Medical Research, Vol. 40, Iss. 1, 2012-01 ,pp. : 377-382

Field House Publishing

Access to resources Recommend Favorite

Phenytoin safety questioned for HLA-B*1502-positive patients

Inpharma, Vol. 1, Iss. 1666, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite

HLA-B locus in Caucasian patients with carbamazepine hypersensitivity

By Alfirevic Ana Jorgensen Andrea L Williamson Paula R Chadwick David W Park B Kevin Pirmohamed Munir

Pharmacogenomics, Vol. 7, Iss. 6, 2006-09 ,pp. : 813-818

Future Medicine

Access to resources Recommend Favorite